According to Acorda Therapeutics 's latest financial reports the company's total assets are $0.36 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $0.39 B | -13.15% |
2021-12-31 | $0.45 B | -28.01% |
2020-12-31 | $0.63 B | -20.89% |
2019-12-31 | $0.79 B | -38.47% |
2018-12-31 | $1.29 B | 8.49% |
2017-12-31 | $1.19 B | -10.75% |
2016-12-31 | $1.34 B | 20.79% |
2015-12-31 | $1.11 B | 4.34% |
2014-12-31 | $1.06 B | 75.43% |
2013-12-31 | $0.60 B | 7.39% |
2012-12-31 | $0.56 B | 48.97% |
2011-12-31 | $0.37 B | 10.93% |
2010-12-31 | $0.34 B | 7.08% |
2009-12-31 | $0.31 B | 13.49% |
2008-12-31 | $0.28 B | 121.12% |
2007-12-31 | $0.12 B | 50.89% |
2006-12-31 | $84.36 M | 148.79% |
2005-12-31 | $33.91 M | 9.46% |
2004-12-31 | $30.98 M | -32.59% |
2003-12-31 | $45.96 M | |
2003-06-30 | $64.8 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Sarepta Therapeutics
SRPT | $3.26 B | 791.12% | ๐บ๐ธ USA |
Repligen
RGEN | $2.82 B | 670.97% | ๐บ๐ธ USA |
Affimed
AFMD | $0.12 B | -65.26% | ๐ฉ๐ช Germany |
BioMarin Pharmaceutical BMRN | $6.84 B | 1,767.53% | ๐บ๐ธ USA |